» Articles » PMID: 34265400

Overexpression of Transcription Factor BLIMP1/prdm1 Leads to Growth Inhibition and Enhanced Secretory Capacity in Chinese Hamster Ovary Cells

Overview
Journal Metab Eng
Date 2021 Jul 15
PMID 34265400
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Chinese hamster ovary (CHO) cells present inherent limitations for processing and secretion of large amounts of recombinant proteins, especially for those requiring complex post-translational processing. To tackle these limitations, we engineered CHO host cells (CHOK1 and CHOS) to overexpress the transcription factor BLIMP1/prdm1 (a master regulator of the highly-secreting phenotype of antibody-producing plasma cells), generating novel CHO cell lines (referred to as CHOB). The CHOB cell lines exhibited decreased cell densities, prolonged stationary phase and arrested cell cycle in G1/G0 phase but simultaneously had significantly greater product titre for recombinant IgG1 (> 2-fold increase) coupled with a significantly greater cell-specific productivities (> 3-fold increase). We demonstrated that the improved productive phenotype of CHOB cells resulted from a series of changes to cell physiology and metabolism. CHOB cells showed a significantly greater ER size and increased protein synthesis and secretion capacity compared to control cells. In addition, CHOB cells presented a metabolic profile that favoured energy production to support increased recombinant protein production. This study indicated that a cell engineering approach based on BLIMP1 expression offers great potential for improving the secretory capacity of CHO cell hosts utilised for manufacture of recombinant biopharmaceuticals. Our findings also provides a greater understanding of the relationship between cell growth and productivity, valuable generic information for improving productive phenotypes for CHO cell lines during industrial cell line development.

Citing Articles

Synergistic promotion of transient transgene expression in CHO cells by PDI/XBP-1s co-transfection and mild hypothermia.

Zhang X, Wang Y, Yi D, Zhang C, Ning B, Fu Y Bioprocess Biosyst Eng. 2024; 47(4):557-565.

PMID: 38416261 DOI: 10.1007/s00449-024-02987-5.


An arrayed CRISPR screen reveals Myc depletion to increase productivity of difficult-to-express complex antibodies in CHO cells.

Bauer N, Oswald B, Eiche M, Schiller L, Langguth E, Schantz C Synth Biol (Oxf). 2022; 7(1):ysac026.

PMID: 36452067 PMC: 9700384. DOI: 10.1093/synbio/ysac026.


Enhanced recombinant protein production in CHO cell continuous cultures under growth-inhibiting conditions is associated with an arrested cell cycle in G1/G0 phase.

Avello V, Torres M, Vergara M, Berrios J, Valdez-Cruz N, Acevedo C PLoS One. 2022; 17(11):e0277620.

PMID: 36374852 PMC: 9662745. DOI: 10.1371/journal.pone.0277620.


Strategies and Considerations for Improving Recombinant Antibody Production and Quality in Chinese Hamster Ovary Cells.

Zhang J, Shan L, Liang F, Du C, Li J Front Bioeng Biotechnol. 2022; 10:856049.

PMID: 35316944 PMC: 8934426. DOI: 10.3389/fbioe.2022.856049.


Harnessing secretory pathway differences between HEK293 and CHO to rescue production of difficult to express proteins.

Malm M, Kuo C, Moradi Barzadd M, Mebrahtu A, Wistbacka N, Razavi R Metab Eng. 2022; 72:171-187.

PMID: 35301123 PMC: 9189052. DOI: 10.1016/j.ymben.2022.03.009.